Espidase D Tablet is a combination medication containing Diclofenac 50mg and Serratiopeptidase 10mg, designed to provide effective relief from pain and inflammation. Diclofenac is a nonsteroidal anti-inflammatory drug (NSAID) that works by inhibiting cyclooxygenase enzymes, thereby reducing the synthesis of prostaglandins responsible for pain and swelling. Serratiopeptidase is a proteolytic enzyme that helps break down inflammatory byproducts and promotes the resolution of inflammation and edema. Together, these components offer synergistic action, making Espidase D Tablet suitable for managing conditions such as musculoskeletal disorders, arthritis, postoperative pain, and soft tissue injuries. The tablet is typically prescribed to alleviate symptoms like joint pain, stiffness, swelling, and discomfort associated with inflammatory conditions. It is important to use this medication under medical supervision, as Diclofenac may cause gastrointestinal irritation, cardiovascular risks, and should be avoided in patients with certain allergies or pre-existing conditions. Serratiopeptidase enhances the anti-inflammatory effect and may improve tissue healing. Patients are advised to follow the prescribed dosage and report any adverse effects such as abdominal pain, rash, or unusual bleeding to their healthcare provider promptly. Espidase D Tablet offers a balanced approach to pain management by combining anti-inflammatory and enzymatic therapy for improved patient outcomes.